CVS is the latest leader in healthcare to make major moves, that should change the way prescription drugs are priced for the better. The announcement of their CVS CostVantage solution features greater transparency on Rx pricing and a simplification of the traditional PBM formulations. While a positive move, some will view the announcement as a reaction to Mark Cuban's Cost Plus Drug Company and Express Script's announcement last month regarding a similar program. Either way, a seismic shift appears on the horizon in the RX drug world and more specifically how PBMs operate within it. Maintaining a pulse on these moves as well as understanding how your employer clients may respond to them will be key in 2024 as these programs materialize. #WinLoss #Fletcher #PBM #healthinsurance https://lnkd.in/guqZ-mdw
